Skip to main content
. 2023 Apr 18;12(5):1175–1195. doi: 10.21037/tcr-22-2526

Table 5. Twelve kinds of chemotherapies with higher sensitivity in the high-risk group and 18 kinds in the low-risk group.

Chemotherapy with higher sensitivity P value
High-risk group
   BMS.536924 4.30E-06
   Bortezomib 4.60E-06
   CGP.60474 3.40E-04
   CGP.082996 4.40E-06
   JW.7.52.1 2.30E-05
   KIN001.135 1.00E-04
   MG.132 2.10E-05
   NVP.TAE684 4.60E-04
   Paclitaxel 2.50E-04
   Rapamycin 3.60E-06
   Roscovitine 7.80E-08
   WZ.1.84 7.20E-06
Low-risk group
   ABT.263 1.90E-12
   AKT.inhibitor.VIII 2.40E-05
   AP.24534 6.00E-06
   AZD.2281 8.50E-04
   AZD7762 2.30E-05
   BIBW2992 9.50E-07
   BX.795 1.80E-08
   CCT007093 1.80E-09
   CCT018159 9.50E-07
   GDC0941 8.90E-10
   Gefitinib 1.40E-04
   JNJ.26854165 2.10E-04
   Midostaurin 4.80E-04
   SB.216763 1.10E-05
   TW.37 1.50E-05
   Vorinostat 2.00E-05
   VX.702 1.40E-07
   ZM.447439 7.70E-05